Search Results

MEDBOTX™ represents the evolution into a broader point-of-care manufacturing platform designed for personalized medicines, peptides and advanced dose formats Potential U.S. peptide reclassification and possible inclusion of select peptides on the Section 503A Bulks List could create a timely opportunity for MEDBOTX™ in compounding pharmacies, hospitals and personalized medicine settings

The agreement establishes a framework for cooperation between the African Medicines Agency (AMA) and the U.S. Pharmacopeia to strengthen regulatory systems, enhance capacity building, and improve access to quality-assured medical products across Africa.

In this episode of Denatured, you’ll hear from Mark Lowdell, CSO & co-founder at INmuneBio Inc. and Vishwas Seshadri, CEO & director at Abeona Therapeutics. We explore how recessive dystrophic epidermolysis bullosa has become a defining case study for gene and cell therapy and what this ultra‑rare disease reveals about the future scalability of advanced therapies.

Waters Corporation announced a new accessory for its TA Instruments Discovery Hybrid Rheometers designed to enable simultaneous electrical impedance and rheological measurements, a critical capability for scientists working on new battery formulations.